METABOLIC AND HEMODYNAMIC-EFFECTS OF MAGNESIUM SUPPLEMENTATION IN PATIENTS WITH ESSENTIAL-HYPERTENSION

被引：48
|
作者：
ZEMEL, PC [1 ]
ZEMEL, MB [1 ]
URBERG, M [1 ]
DOUGLAS, FL [1 ]
GEISER, R [1 ]
SOWERS, JR [1 ]
机构：
[1] CIBA GEIGY CORP,DIV PHARMACEUT,SUMMIT,NJ 07901
来源：
AMERICAN JOURNAL OF CLINICAL NUTRITION | 1990年 / 51卷 / 04期
关键词：
Blood pressure; Cation metabolism; Lipids; Magnesium;
D O I：
10.1093/ajcn/51.4.665
中图分类号：
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号：
100403 ;
摘要：
The effect of magnesium supplementation on blood pressure, erythrocyte cation metabolism, and serum lipids was evaluated in 13 patients with mild hypertension. After randomization and a 3-wk placebo run-in period, seven patients received 40 mmol Mg asparate (20 mmol elemental Mg twice daily) and six received placebo for 3 mo. In comparison with placebo treatment, magnesium aspartate therapy had no effect on blood pressure, lipid concentrations, or erythrocyte cation metabolism. These results demonstrate that in magnesium-repleted hypertensive subjects, magnesium supplementation does not affect blood pressure or lipids probably because magnesium has no effect on cellular cation metabolism in magnesium-replete individuals.
引用
收藏
页码：665 / 669
页数：5
相关论文
共 50 条
  • [21] HEMODYNAMIC-EFFECTS OF AMOSULALOL (YM-09538) IN PATIENTS WITH ESSENTIAL-HYPERTENSION
    SAITO, T
    YAMAMOTO, K
    INAGAKI, Y
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1992, 52 (05): : 702 - 707
  • [22] HEMODYNAMIC-EFFECTS OF RO 23-6152 IN PATIENTS WITH ESSENTIAL-HYPERTENSION
    FOLKERS, HBM
    VANZWIENEN, JCW
    BOER, P
    KLEINBLOESEM, CH
    GEYSKES, GG
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 41 (04) : 307 - 311
  • [23] ACUTE HEMODYNAMIC-EFFECTS OF INTRAVENOUS NICARDIPINE IN ESSENTIAL-HYPERTENSION
    MAUREL, C
    CHAIGNON, M
    GUEDON, J
    CLINICAL AND EXPERIMENTAL HYPERTENSION PART A-THEORY AND PRACTICE, 1987, 9 (11) : 1917 - 1917
  • [24] RENAL HEMODYNAMIC-EFFECTS OF KETANSERIN THERAPY IN ESSENTIAL-HYPERTENSION
    GONZALEZ, D
    RAM, CVS
    LUGO, C
    KAPLAN, N
    RALAKIS, J
    HENDERSON, J
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1987, 41 (02) : 221 - 221
  • [25] RENAL HEMODYNAMIC-EFFECTS OF KETANSERIN THERAPY IN ESSENTIAL-HYPERTENSION
    RAM, CVS
    GONZALEZ, DG
    KAPLAN, NM
    RALAKIS, JM
    HENDERSON, JD
    LUGO, CE
    ZACHARIAH, N
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1987, 10 : S78 - S80
  • [26] HEMODYNAMIC-EFFECTS OF PINACIDIL AND HYDRALAZINE IN UNTREATED ESSENTIAL-HYPERTENSION
    CARLSEN, J
    LUND, JO
    TRAPJENSEN, J
    ACTA PHYSIOLOGICA SCANDINAVICA, 1982, : 42 - 42
  • [27] HEMODYNAMIC-EFFECTS OF INDAPAMIDE IN CHRONIC TREATMENT OF ESSENTIAL-HYPERTENSION
    RICCIARDELLI, B
    VOLPE, M
    DELUCA, N
    CUOCOLO, A
    BUZZETTI, G
    DEGIOVANNI, F
    TRIMARCO, B
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1984, 36 (01): : 201 - 210
  • [28] ACUTE HEMODYNAMIC-EFFECTS OF PINACIDIL AND HYDRALAZINE IN ESSENTIAL-HYPERTENSION
    CARLSEN, JE
    KARDEL, T
    LUND, JO
    MCNAIR, A
    TRAPJENSEN, J
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1985, 37 (03) : 253 - 259
  • [29] NATRIURETIC AND RENAL HEMODYNAMIC-EFFECTS OF NICARDIPINE IN ESSENTIAL-HYPERTENSION
    CHAIGNON, M
    BELLET, M
    LUCSKO, M
    RAPOUD, C
    GUEDON, J
    KIDNEY INTERNATIONAL, 1988, 34 : S184 - S186
  • [30] CARDIAC AND HEMODYNAMIC-EFFECTS OF VERAPAMIL THERAPY IN ESSENTIAL-HYPERTENSION
    FLETCHER, PJ
    HORVATH, JS
    BAILEY, BP
    TILLER, D
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1986, 16 (04): : 571 - 571
12345